Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus

Background. Hepatitis B virus (HBV) infections are perinatally transmitted from chronically infected mothers. Supplemental antiviral therapy during late pregnancy with lamivudine (LAM), telbivudine (LdT), or tenofovir (TDF) can substantially reduce perinatal HBV transmission compared to postnatal im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenjun, Wang, Jingjing, Dang, Shuangsuo, Zhuang, Guihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811175/
https://www.ncbi.nlm.nih.gov/pubmed/27042389
http://dx.doi.org/10.7717/peerj.1709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811175/
https://www.ncbi.nlm.nih.gov/pubmed/27042389
http://dx.doi.org/10.7717/peerj.1709

Ejemplares similares